Mobile Payment Market Size Is Expected To Reach USD 273.1 Billion by 2028

 Mobile Payment Market Growth & Trends

The global mobile payment market size is expected to reach USD 273.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 31.8% from 2021 to 2028. The rising penetration rate of smartphones and the growing preference for contactless payments across the globe are expected to drive the growth of the market over the forecast period. Continued integration of biometric authentication into mobile payments also bodes well for the growth of the market. According to a study published by Biometric Update, the use of biometrics in mobile commerce, app-based purchase, and mobile device payments is expected to emerge into a market worth USD 3.0 trillion by 2025.

Solution providers are aggressively facilitating smart parking payment solutions. For instance, in February 2021, Google announced a new feature that allows users to pay for parking slots within Google Maps. The feature would be available for Android users in over 400 U.S. cities and would soon be rolled out for iPhones also. Transit companies are adopting mobile ticking aggressively, thereby contributing to the growth of the market. For instance, in August 2020, Saskatoon Transit, a mass transportation system provider, announced the rollout of a new service that allows people to buy tickets on their smartphones.

Smart speaker payments are gaining traction and are expected to play a vital role in driving the growth of the market. Leading developers of smart speaker payment solutions, including Amazon, Apple, and Google, are pursuing strategic initiatives, such as mergers and acquisitions and strategic partnerships, to promote the technology. For instance, in August 2019, NatWest, a retail banking company, announced a partnership with Google for a pilot project that envisages the company allowing its customers to carry out banking transactions from home using smart speakers or Google Assistant.

The outbreak of the COVID-19 pandemic is expected to have a positive impact on the market. The restrictions imposed by various governments across the globe on the movement of people as part of the efforts to arrest the spread of coronavirus and the growing preference among individuals to stay at home in the wake of the outbreak of the pandemic have particularly triggered a paradigm shift in the consumers’ shopping behaviors. Consumers are typically trying to avoid any physical contact while making payments and prefer contactless payments at the point of sale. According to the statistics provided by East West Bank, the usage of contactless payment modes in the U.S increased 150% over the year in 2020. Moreover, 87% of the consumers preferred using contactless payment options while shopping at stores.

Request a free sample copy or view report summary: Mobile Payment Market Report

Mobile Payment Market Report Highlights

• The near field communication segment is anticipated to register the highest CAGR over the forecast period owing to the growing preference for NFC-based payment solutions among merchants and customers
• The B2C segment is anticipated to register the highest CAGR from 2021 to 2028 owing to the growing use of mobile devices for making personal payments
• The proximity payment segment is expected to register the highest CAGR over the forecast period owing to the rising adoption of payment solutions based on NFC, Wi-Fi, and Bluetooth connectivity
• The retail and e-commerce segment is expected to emerge as the fastest-growing segment over the forecast period owing to the increasing partnerships between mobile payment providers and retailers
• In Asia Pacific, the market accounted for the largest revenue share in 2020. Increasing use of smartphones for online shopping of packaged food and drinks is driving the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mobile-payment-market

Mobile Payment Market Segmentation

Grand View Research has segmented the global mobile payment market based on technology, payment type, location, end use, and region:

Mobile Payment Technology Outlook (Revenue, USD Billion, 2016 - 2028)

• Near Field Communication
• Direct Mobile Billing
• Mobile Web Payment
• SMS
• Interactive Voice Response System
• Mobile App
• Others

Mobile Payment Type Outlook (Revenue, USD Billion, 2016 - 2028)

• B2B
• B2C
• B2G
• Others

Mobile Payment Location Outlook (Revenue, USD Billion, 2016 - 2028)

• Remote
• Proximity

Mobile Payment End-use Outlook (Revenue, USD Billion, 2016 - 2028)

• BFSI
• Healthcare
• IT & Telecom
• Media & Entertainment
• Retail & E-commerce
• Transportation
• Others

Mobile Payment Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players of Mobile Payment Market

• Google (Alphabet Inc.)
• Alibaba Group Holdings Limited
• com, Inc.
• Apple Inc.
• American Express Company
• M-Pesa
• Money Gram International
• PayPal Holdings, Inc.
• Samsung Electronics Co., Ltd.
• Visa Inc.
• WeChat (Tencent Holdings Limited)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

COVID-19 Vaccine Development Tools Market to Record an Exponential CAGR by 2028: Grand View Research Inc.

 COVID-19 Vaccine Development Tools Market Growth & Trends

The global COVID-19 vaccine development tools market size is expected to reach USD 30.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2021 to 2028. Research professionals across the globe, are rapidly persuading the identification and development of viable candidates to develop COVID-19 immunization shots. This is attributed to the persisting devastation of SARS-CoV-2 across the globe. Additionally, second waves of SARS-CoV-2 infection were expected to coincide with the beginning of winter in the northern hemisphere, indicating the crucial period in the pandemic’s timeline.

Thus, the development of a viable immunization shot is imperative to mitigate the global impact of COVID-19. Acknowledging this need, entities engaged in the development of effective inoculation against COVID-19, are aiming at 4 potential key vaccine candidates, namely, mRNA, recombinant, inactivated, and replication-deficient viral vector. These 4 candidates are the key areas of focus, and the integration of mass spectrometry and chromatography for candidate characterization is common across the development process of all the above candidates.

The spike protein (S-protein) is the most preferred target site with respect to the COVID-19 vaccine target discovery. This is attributed to the fact that the S-proteins are spread throughout the surface of the COVID-19 molecule, which enables attachment to host cell receptors, in turn ensuring easy entry of the virus into the host cell. Active government initiatives aimed at enabling the fast-track development of COVID-19 boosters are expected to create a favorable environment for entities operating in the industry.

For instance, in April 2020, the Access to COVID-19 Tools (ACT) Accelerator was launched aimed at speeding up the delivery and development of COVID-19 boosters. This initiative is inclusive of a health systems connector that supports the delivery of required resources to countries. The tools are also pooled under the umbrella mechanism, namely, the COVAX Facility to ensure effective procurement as well as equitable access to, COVID-19 vaccination and development tools. The ACT Accelerator targets to deliver around 2 billion doses by the end of 2021, across the globe.

Request a free sample copy or view report summary: COVID-19 Vaccine Development Tools Market Report

COVID-19 Vaccine Development Tools Market Report Highlights

• Laboratory technologies have generated the highest revenue in 2020 and this segment is anticipated to maintain its dominance throughout the forecast period
• Significant growth in the adoption of pre-existing laboratory technologies such as PCR, 3D and 2D cell culture products, and flow cytometry is attributive to the segment’s dominance
• The PCR and qPCR segment dominated the market in terms of revenue share in 2020
• The WHO recommends the implementation of rRT-PCR in surveillance of participants for effective COVID-19 vaccine evaluation, which has supplemented a significant surge in the uptake of PCR products
• Detecting new mutations in SARS-CoV-2 enables research professionals to reconstruct unknown infection routes along with establishing a molecular basis for COVID-19 vaccine design
• This has widely promoted the usage of NGS particularly across molecular typing and genomic epidemiology applications, making it the fastest-growing segment throughout the forecast period
• Interactive web tools have emerged as dominant online technologies employed in COVID-19 vaccine development and research
• Online interactive web tools have gained sufficient traction amongst the researchers and vaccine developers as these entail interactive graphs, maps, and dashboards that assist in effective monitoring of vaccine development while avoiding any misinformation
• Vaccine research has witnessed the highest penetration of COVID-19 vaccine development tools, leading to the segment’s largest share in 2020
• Large-scale adoption of tools associated with nucleic acid isolation and purification, real-time PCR, Sanger sequencing, mass spectrometry, and NGS among others has contributed to the segment’s dominance
• The contract research organization (CROs) end-use segment is expected to grow at a fast pace through 2021 - 2028. Partnerships with CROs are proving integral as they ensure access to a vast number of resources along with expanded expertise
• North America dominated the market and accounted for the largest revenue share in 2020; U.S. ranked 1^stin this region, in terms of revenue
• More than 20% of the vaccines being developed across the globe hail from the U.S., thus, providing immense lucrative opportunities for the market players operational in the country

Access Press Release@ https://www.grandviewresearch.com/press-release/global-covid-19-vaccine-development-tools-market

COVID-19 Vaccine Development Tools Market Segmentation

Grand View Research has segmented the global COVID-19 vaccine development tools market on the basis of technology, application, end use, and region:

COVID-19 Vaccine Development Tools Technology Outlook (Revenue, USD Million, 2020 - 2028)

• Laboratory Technologies
  • Next Generation Sequencing
  • PCR & qPCR
  • Flow Cytometry
  • Spectrometry
  • Microscopy&Electron Microscopy
  • Preparative & Process Chromatography
  • Nucleic Acid Isolation & Purification
  • Transfection Electroporation
  • Cell Culture
  • Automated Liquid Handling
• Online Technologies
  • Interactive Web Technologies
  • Vaccine Management & Tracker Technologies

COVID-19 Vaccine Development Tools Application Outlook (Revenue, USD Million, 2020 - 2028)

• Vaccine Research
• Vaccine Process Development
• Vaccine Quality Assurance/Quality Control

COVID-19 Vaccine Development Tools End-use Outlook (Revenue, USD Million, 2020 - 2028)

• Pharma & Biopharma Companies
• Contract Research Organization (CROs)
• Academic & Research Institutes

COVID-19 Vaccine Development Tools Regional Outlook (Revenue, USD Million, 2020 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
  • France
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of COVID-19 Vaccine Development Tools Market

• Thermo Fisher Scientific, Inc.
• Celerion
• Cole-Parmer Instrument Company, LLC.
• Pfizer Inc.
• Sartorius AG
• STEMCELL Technologies Inc.
• AB SciexPte. Ltd.
• Illumina, Inc.
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Danaher
• Merck KGaA
• Qiagen N.V.
• Shimadzu Corporation
• Eurofins Scientific
• Charles River Laboratories
• Takara Bio Inc.
• PerkinElmer Inc.
• Fluidigm
• OLYMPUS CORPORATION
• Avantor, Inc.
• Polyplus Transfection
• Hamilton Company
• Aurora Biomed Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pulmonary Arterial Hypertension Market Size Is Expected To Reach USD 7.7 Billion by 2028

 Pulmonary Arterial Hypertension Market Growth & Trends

The global pulmonary arterial hypertension market size is expected to reach USD 7.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.9% from 2021 to 2028. Increasing prevalence rates of pulmonary arterial hypertension (PAH) and government support for the development of orphan drugs are fueling the market growth.

The COVID-19 pandemic did not have much impact on the PAH market due to the normal demand for PAH drugs by the patients. All the market players reported positive growth rates in their year-on-year revenues from 2019 to 2020. However, the supply chains were disrupted to a certain level due to lockdowns in many nations globally. Overall, the impact was neutralized due to the continuous demand for drugs.

The cases of PAH are rising in the range of 100,000 to 200,000 per year. However, in the past few years, the occurrence of this disorder is intensifying due to the risk factors such as alcohol/tobacco consumption, HIV, sedentary lifestyle, smoking, and other idiopathic conditions.

The existence of a large geriatric population having lower levels of immunity is prone to PAH and associated diseases is a high impact-rendering factor for the growth of the PAH market over the forecast period. Though the beginning age for PAH is 45 years, it is often observed to occur in a population over 60 years of age.

Government initiatives such as the Rare Disease Act 2002 and The Orphan Drug Act (ODA) 1983 are also anticipated to support market growth. These are the two most vital acts that promote the ethical usage and distribution of orphan drugs. The development of orphan drugs is promoted by the National Organization of Rare Disorders and has a smaller market share.

Robust drug pipeline and new product combination awaiting approval or launch are anticipated to heighten the market competitiveness over the forecast period. In December 2020, Acceleron Pharma received orphan drug designation for Sotatercept from the European Commission and is available for commercial use in the European markets.

Request a free sample copy or view report summary: Pulmonary Arterial Hypertension Market Report

Pulmonary Arterial Hypertension Market Report Highlights

• By drug class, prostacyclin and prostacyclin analogs are projected to witness lucrative growth over the forecast period. The sales of these drugs are anticipated to grow sharply in the future, primarily due to the growth expected in oral prostacyclin agents
• North America dominated the PAH market with over 55.0% share in 2020. This is attributed to its supportive infrastructure for the development and distribution of high-quality therapies. In addition, the availability of reimbursement on PAH therapies support the market growth
• Asia Pacific is anticipated to expand at the fastest CAGR of 5.9% over the forecast period due to its large population base, rapid economic developments, and improving healthcare systems. Besides, the high burden of diseases such as HIV, which are responsible for the development of PAH, foster the growth of this regional market
• The market is consolidated and competitive. Players enjoy the benefit of high entry barriers to other firms due to the high price interdependency

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pulmonary-arterial-hypertension-pah-market-size-report

Pulmonary Arterial Hypertension Market Segmentation

Grand View Research has segmented the global pulmonary arterial hypertension market based on drug class and region:

Pulmonary Arterial Hypertension Drug Class Outlook (Revenue, USD Million, 2016 - 2028)

• Prostacyclin and Prostacyclin Analogs
• Soluble Guanylate Cyclase (SGC) Stimulators
• Endothelin Receptor Antagonist (ERA)
• Phosphodiesterase 5 (PDE-5)

Pulmonary Arterial Hypertension Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Pulmonary Arterial Hypertension Market

• Johnson & Johnson Services, Inc.
• United Therapeutics Corporation
• Pfizer, Inc.
• Acceleron Pharma, Inc.
• Gilead Sciences, Inc.
• Bayer AG
• GlaxoSmithKline Plc. (GSK)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Exoskeleton Market Size Is Expected To Reach USD 953.1 Million by 2028

 Exoskeleton Market Growth & Trends 

The global exoskeleton market size is expected to reach USD 953.1 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 20.5% from 2021 to 2028. The rise in the prevalence of road accidents and stroke and the growing geriatric population is increasing the adoption of exoskeletons for improving mobility, thereby aiding the market growth. According to the data published by the National Safety Council in March 2021, an estimated 42,060 individuals died in road mishaps in 2020, a year in which people traveled significantly less (13%) owing to the COVID-19 pandemic, an increase of 8% over 2019. It further stated that around 4.8 million people were badly injured in 2020. Exoskeletons are anticipated to continuously evolve in complexity in the forthcoming years owing to the implementation of machine learning and artificial intelligence (AI), resulting in smarter and more competent robots.

Based on mobility, the mobile exoskeleton segment accounted for the largest revenue and volume share in 2020. The development of innovative mobile exoskeletons by manufacturers for the elderly and disabled population is boosting the adoption of mobile exoskeletons. The segment is also anticipated to witness the fastest growth during the forecast period. However, complications and high costs associated with designing mobile systems are expected to hamper the market growth as these factors ultimately increase the costs of the final product.

In 2020, the powered technology segment accounted for the largest revenue and volume share. This is attributed to the increasing adoption of powered exoskeleton for SCI rehabilitation with different levels of injury. In addition, increasing benefits offered by these products in restoring mobility, increasing functioning, and improving the quality of life and health status for wheelchair-bound patients are bolstering the adoption of powered exoskeletons. The non-powered technology segment is anticipated to register the fastest growth rate during the forecast period. This is credited to the increasing product launches and the increasing demand for non-powered exoskeletons for reducing the risks for developing low back pain in bent forward work-related positions.

In 2020, the lower body extremity segment accounted for the largest revenue and volume share owing to the increasing prevalence of lower body disabilities. The upper body extremity segment is anticipated to register the fastest growth rate during the forecast period. This is attributed to the rising adoption of upper body exoskeletons in managing activities of daily living among the disabled patient population.

Based on end use, healthcare accounted for the largest revenue and volume share in 2020. An increase in the number of road accidents requiring rehabilitation services post-surgery and a surge in the prevalence of spinal cord injuries are aiding the segment growth across the globe. The industry segment is anticipated to be the fastest-growing segment during the forecast period as exoskeletons help in enhancing strength and reducing physical strain on workers in various industries.

In 2020, North America dominated the global market in terms of revenue. This can be attributed to the increasing adoption of innovative and advanced technologies, the growing geriatric population, and the rising disabled population. Asia Pacific is anticipated to be the fastest-growing regional market in terms of revenue during the forecast period owing to evolving care models, infrastructure investments, and increasing demand for exoskeleton among a large patient pool for rehabilitation.

Request a free sample copy or view report summary: Exoskeleton Market Report

Exoskeleton Market Report Highlights

• The mobile mobility segment dominated the market in 2020 owing to the benefits offered in enhancing strength without compromising on the freedom of movement
• The powered technology segment dominated the market in 2020 owing to an increase in the influx of regulatory approved solutions
• The lower body extremity segment dominated the market in 2020 owing to an increase in the prevalence of lower body disabilities
• The healthcare end-use segment dominated the market in 2020 owing to a surge in advancements in this sector
• North America held the largest share in terms of revenue in 2020 owing to the rising geriatric population and increasing number of U.S. FDA approvals in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-exoskeleton-market

Exoskeleton Market Segmentation

Grand View Research, Inc. has segmented the global exoskeleton market on the basis of mobility, technology, extremity, end use, and region:

Exoskeleton Mobility Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Mobile
• Fixed/Stationary

Exoskeleton Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Powered
• Non-powered

Exoskeleton Extremity Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Upper Body
• Lower Body
• Full Body

Exoskeleton End-use Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Healthcare
• Military
• Industry

Exoskeleton Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • Italy
  • France
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Exoskeleton Market

• Ekso Bionics
• Hocoma
• Lockheed Martin Corporation
• Suit X (U.S. Bionics, Inc.)
• Rex Bionics Plc.
• RB3D
• ReWalk Robotics Ltd.
• Cyberdyne, Inc.
• ActiveLink (Panasonic Corporation)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

COVID-19 Vaccine Packaging And Delivery Devices Market Trends, Growth Prospects To 2028: Grand View Research Inc.

 COVID-19 Vaccine Packaging And Delivery Devices Market Growth & Trends

The global COVID-19 vaccine packaging and delivery devices market size is anticipated to reach USD 3.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.4% from 2022 to 2028. High demand for immunization for the ongoing pandemic and manufacturer's initiatives to expand their production capacities are the factors expected to boost the demand for packaging materials.

The hurtling vaccine inoculation rate and growing public trust in COVID-19 vaccines are anticipated to fuel the growth of the market. According to the global attitude towards the COVID-19 vaccine survey, the share of people going for immunization has increased significantly in 2021. The increasing public willingness to get vaccinated early is expected to drive the manufacturing and distribution process, propelling market growth over the forecast period.

The increasing funding and investments in R&D activities specific to the development of an innovative vaccine, packaging material, and delivery devices are anticipated to fuel the growth of the market during the forecast period. For instance, the federal government of the U.S. invested USD 143 million to develop plastic alternatives to conventional glass vials for the storage of biological liquids.

Scientists around the world are investigating the scope of needles free delivery that would eliminate the need for vials and syringes hindering the market growth in the extended run. For instance, scientists at the University of Texas developed a film-based peelable inexpensive COVID-19 vaccine delivery device. On the other side, Bharath Biotech develops an innovative nasal vaccine to battle COVID-19.

Request a free sample copy or view report summary: COVID-19 Vaccine Packaging And Delivery Devices Market Report

COVID-19 Vaccine Packaging And Delivery Devices Market Report Highlights

• Based on the product, syringes held the largest proportion of the market share in 2021
• Prefilled syringesare expected to grow at the fastest rate owing to their advantages such as usage simplicity, low cost, and ease of distribution
• The plastic vials segment is anticipated to register a lucrative CAGR during the forecast period
• The glass vials segment accounted for a major proportion of the market share in 2021
• The empty syringes segment is expected to grow at a healthy rate due to the speeding COVID-19 vaccination rates globally
• North America holds the largest share in this market. The U.S. is one of the major suppliers globally
• In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to building people trust in the approved vaccines and the public readiness to get vaccinated

Access Press Release@ https://www.grandviewresearch.com/press-release/global-covid-19-vaccine-packaging-delivery-device-market

COVID-19 Vaccine Packaging And Delivery Devices Market Segmentation

Grand View Research has segmented the global COVID-19 vaccine packaging and delivery devices market on the basis of product and region:

COVID-19 Vaccine Packaging & Delivery Device Product Outlook (Revenue, USD Million, 2020 - 2028)

• Vials
  • Glass
  • Plastic
• Syringes
  • Empty
  • Prefilled

COVID-19 Vaccine Packaging & Delivery Device Regional Outlook (Revenue, USD Million, 2020 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of COVID-19 Vaccine Packaging And Delivery Devices Market

• BD
• Braun Melsungen AG
• Hindustan Syringes & Medical Devices Ltd.
• Terumo
• NIPRO Medical Corporation
• SCHOTT AG
• Gerresheimer AG
• Cardinal Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Australia Clear Aligners Market Major Key Players And Latest Trend Analysis Till 2028: Grand View Research Inc.

 Australia Clear Aligners Market Growth & Trends

The Australia clear aligners market size is expected to reach USD 534.3 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 28.7% from 2021 to 2028. Clear aligners are invisible and discreet braces developed from thermoformed materials like copolyester or polycarbonate plastic and CAD 3D printing technology, acting as an alternative to traditional braces. According to FDA, the clear aligner system helps in positioning the teeth through continuous gentle force and is developed to treat mild to moderate malocclusions.

According to Orthodontics Australia, around 55.0% of the Australian population feels self-conscious about their teeth. It also states that around 62.0% of Australians are willing to fix their misaligned teeth. Additionally, around 3,00,000 individuals in Australia have braces and more than a quarter of them are above the age of 19, according to Wilkins Orthodontics. This can prove to be a significant driver for the growth of the market in the country as people are readily adopting a lower cost, comfortable, and aesthetically appealing alternative to traditional metal braces.

Technological advancements and the growing demand for customized invisible braces are significant factors responsible for market growth. Companies like Align Technology and DynaFlex are constantly bringing in newer computer-aided technology in the market. According to Australian News, around 40,000 Australians use clear aligner therapy for teeth straightening annually and 10% to 15% of Australian dentists use CAD/CAM technology for dental treatments.

The advent of Covid-19 has impacted the overall dental industry and the market for clear aligners. However, during the pandemic, the sales of direct-to-consumer invisible braces witnessed a surge as it involves minimal clinical oversight and does not require patients to visit a dental office. Moreover, as a step to assist doctors and stimulate their doctor-directed aligner products demand, in 2020, Align Technology did not implement annual price increases on various invisible braces.

Request a free sample copy or view report summary: Australia Clear Aligners Market Report

Australia Clear Aligners Market Report Highlights

• The teenage segment dominated the market in 2020, as teenagers are increasingly opting for invisible braces because of their inconspicuous characteristics and comfort
• The group practices segment accounted for the largest revenue share in 2020 as they are readily adopting invisible braces and are highly equipped with advanced digital technologies
• The offline distribution segment held the highest revenue share in 2020, as the doctor directed clear aligner systems are still highly recommended by Dental Associations and also offer clinical oversight
• The online distribution segment is expected to witness the highest CAGR over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/australia-clear-aligners-market-analysis

Australia Clear Aligners Market Segmentation

Grand View Research has segmented the Australia clear aligners market on the basis of age, end use, and distribution channel:

Australia Clear Aligners Age Outlook (Revenue, USD Million, 2016 - 2028)

• Adult
• Teenage

Australia Clear Aligners End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Stand Alone Practices
• Group Practices
• Direct to Consumer

Australia Clear Aligners Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Offline
• Online

List of Key Players of Australia Clear Aligners Market

• Align technology
• Byte
• SmilePath
• EZSmile
• Beam Australia
• WonderSmile
• SmileStyler
• SmileDirectClub

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Lab Automation Market Predicted to Witness Steady Growth During the Forecast Period

 Lab Automation Market Growth & Trends

The global lab automation market size is expected to reach USD 8.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. Key drivers of the market include a rise in the gap between the availability of trained laboratory personnel and the demand for laboratory procedures and high reproducibility and accuracy obtained through lab automation.

Other drivers facilitating growth include smaller volumes of reagents and samples required, personnel safety, progressing drug discovery, miniaturization of the process thus leading to low reagent cost, and clinical diagnostics. The market is anticipated to witness various lucrative opportunities for growth owing to an increasing prevalence of infectious diseases and a rising number of clinical studies which are expected to increase the number of diagnostic tests performed in the laboratories.

The rise in applications of lab automation is one of the major factors anticipated to boost growth during the forecast period. Clinical chemistry applications have been replaced by lab automation for tasks such as solid-phase extraction, powder dosing, dilution to weight, sample extraction, and sample preparation for analysis facilitating increasing productivity, reliable results, and interpretation, safer working conditions for laboratory personnel, lower costs, reduced laboratory space, and reduced turnaround times. Similarly, for synthetic biology workflow processes, tasks such as DNA fragment construction, the culture of the host organism, colony selection, final data collection, and analysis have been replaced by automation processes. Therefore, an increase in the number of applications is expected to fuel their adoption in the near future.

North America’s market accounted for the largest revenue share in 2020 and is expected to maintain its position during the forecast period. The growth is attributed to well-established healthcare infrastructure, an increase in the adoption of these systems, the local presence of major players, a supportive reimbursement framework, and the increasing prevalence of chronic and infectious diseases.

Major players are mostly involved in contributing to innovations and technological advancements, impacting market growth positively. A rise in product launches undertaken by dominant players is anticipated to boost the market growth. In April 2019, Qiagen launched the QIAstat-Dx in Europe, which provides a fully integrated and one-step molecular analysis of common syndromes and oncological and other diseases. This initiative was undertaken by the company to enhance the distribution of its products in Europe. Such initiatives are expected to drive the market over the forecast period.

Request a free sample copy or view report summary: Lab Automation Market Report

Lab Automation Market Report Highlights

• The continuous flow segment dominated the overall market in terms of revenue in 2020 owing to the high adoption of continuous flow in laboratories for providing high-quality services
• The total automation systems segment accounted for the largest revenue share in 2020 owing to various benefits offered by these systems, advancements in the field of automation, and a rise in demand for flexible automation solutions for analytical measurements
• The clinical chemistry analysis segment held the largest revenue share in 2020 owing to technological advancements, increase in automation systems provided by market players, and growth in the usage of automated systems owing to their benefits, such as the reduced risk of contamination and elimination of human error, among other benefits
• The market is anticipated to be dominated by the North American region owing to the presence of well-established healthcare infrastructure, which has led to an increase in the adoption of laboratory automation systems in the region 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-lab-automation-market

Lab Automation Market Segmentation

Grand View Research has segmented the global lab automation market on the basis of process, automation type, end use, and region:

Lab Automation Process Outlook (Revenue, USD Million, 2016 - 2028)

• Continuous Flow
  • By Workflow
    • Sequential Processing
    • Parallel Processing
  • By Components
    • Consumables
    • Equipment
  • Discrete Processing
    • By Method
      • Centrifugal Discrete Processing
      • Random Access Discrete Processing
    • By Components
      • Consumables
      • Equipment
    • By Workflow
      • Dependent Analysis
      • Independent Analysis

Lab Automation Type Outlook (Revenue, USD Million, 2016 - 2028)

• Total Automation Systems
  • By Steps
    • Pre-analysis
      • Centrifugation
      • Sample Preparation
      • Sample Sorting    
    • Transport Mechanisms
    • Liquid Handling
    • Sample Storage
    • Sample Analysis
  • Modular Automation Systems
    • By Steps
      • Specimen Acquisition & Identification & Labelling
      • Transport Mechanisms
      • Sample Preparation
      • Sample Loading & Aspiration
      • Reagent Handling & Storage
      • Sample Analysis & Measurements

Lab Automation End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Clinical Chemistry Analysis
• Photometry & Fluorometry
• Immunoassay Analysis
• Electrolyte Analysis
• Other end-uses

Lab Automation Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Lab Automation Market

• Qiagen N.V.
• PerkinElmer Inc.
• Thermo Fisher Scientific, Inc.
• Siemens Healthineers
• Danaher Corporation
• Agilent Technologies, Inc.
• Bio Tek Instruments, Inc.
• Eppendorf AG
• Hudson Robotics
• Aurora Biomed Inc.
• BMG LABTECH GMBH
• Tecan Group Ltd.
• Hamilton Company
• Hoffmann-La Roche

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Refractive Surgery Devices Market To Make Great Impact In The Near Future by 2028: Grand View Research Inc.

 Refractive Surgery Devices Market Growth & Trends

The global refractive surgery devices market size is expected to reach USD 290.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.7% from 2021 to 2028. As a result of the COVID-19 pandemic, consumers have started spending more time on digital devices. The trend of working from home has contributed to an increase in eyestrain, dry eye, and myopia. Furthermore, the growth of the geriatric population has increased the demand for refractive surgery devices. According to the National Institute on Aging (NIA), the geriatric population would be about 72 million individuals by 2030.

Refractive surgery allows a person to be more independent by eliminating the need for spectacles or contact lenses. Consumers have managed their personal spending and emphasized health and wellbeing during the pandemic, which has increased the demand for refractive surgery devices. Whereas the market for refractive surgery devices is being hindered in developing countries due to a shortage of surgical equipment to address refractive defects.

Many companies in the refractive surgery devices sector have moved their focus to the development of advanced refractive surgery devices and are conducting various research programs for the same. As per the World Health Organization, the cost of uncorrected refractive error in terms of direct and indirect global productivity loss is estimated to be USD 269 billion. Myopia is the leading cause of distance refractive error, according to current estimations and demographic trends, and will likely remain so in the future. Therefore, a growing unaddressed patient pool with refractive errors is expected to contribute to the demand for refractive surgery, which is expected to propel the overall market growth.

Request a free sample copy or view report summary: Refractive Surgery Devices Market Report

Refractive Surgery Devices Market Report Highlights

• By application, the myopia segment held the largest share of 27.1% in 2020 and is anticipated to grow at a moderate rate during the forecast period due to an increase in the cases of myopia globally
• Based on product, the lasers segment dominated the market with a revenue share of 34.9% in 2020 and is expected to grow at the fastest rate during the forecast period as it is a safest and quickest refractive surgery
• In terms of end use, ambulatory surgical centers are expected to exhibit the highest growth rate during the forecast period due to the convenience, closeness, and reduced costs for patients and insurer
• The hospitals end-use segment held the largest share of nearly 37.0% in 2020  due to the growing number of hospitals in emerging countries and the adoption of refractive surgery devices
• In Asia Pacific, the market is expected to register the fastest growth rate of 10.0% over the forecast period due to the rising number of optical disorders in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-refractive-surgery-devices-market

Refractive Surgery Devices Market Segmentation

Grand View Research has segmented the global refractive surgery devices market based on application, product, end use, and region:

Refractive Surgery Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Myopia
• Hyperopia
• Astigmatism
• Presbyopia
• Dry Eyes

Refractive Surgery Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Lasers
• Microkeratome
• Aberrometers
• Others

Refractive Surgery Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgery Centers
• Ophthalmology Clinics

Refractive Surgery Devices Regional Outlook (Revenue, USD Million,2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

 List of Key Players of Refractive Surgery Devices Market

• Johnson & Johnson Services, Inc.
• Carl Zeiss Meditec AG
• Alcon
• Bausch & Lomb Incorporated
• Quantel Medical
• TOPCON CORPORATION
• Essilor
• NIDEK CO., LTD.
• SCHWIND eye-tech-solutions

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Semi-Autonomous Vehicle Market to Witness Exponential Growth by 2028: Grand View Research Inc.

 Semi-Autonomous Vehicle Market Growth & Trends

The global semi-autonomous vehicle market demand is anticipated to reach 60.1 million units by 2028, exhibiting a CAGR of 20.8% over the forecast period, according to a new report by Grand View Research, Inc. The rapid growth can be attributed to the rising adoption of driver-assisted technologies, thereby enhancing the driving experience. The confluence of abilities such as electronic braking, adaptive cruise control, and obstacle detection; and continuous technological innovations happening in driving technologies offer an impetus to market growth. Semi-autonomous cars also promise drivers the ability to practice safer driving over the forecast period, thus driving higher adoption. The availability of forwarding collision and lane assistance and progressive learning models in cars helps to remove human error, thus reducing accidents.

The rising technological development of semi-autonomous cars has increased integration with connected technologies, thus increasing efficiency by minimizing human error. Semi-autonomous vehicles can increase the efficiency of vehicles as they would offer real-time traffic updates, enhanced driving assistance systems, and connected cars. Semi-automatic cars also offer the ability to indulge in intelligent driving, thus helping in changing routes accordingly. Thus, the vehicles would be more efficient and secure as they would not result in the wastage of fuel in traffic jams and ensure passenger safety.

Artificial Intelligence (AI) offers promising growth opportunities to the semi-autonomous cars market due to its applications in several use cases within automotive. The implementation of Ai-models aids in pattern and obstacle recognition, which helps understand verbal sounds, non-verbal cues, and gestures. There has been an increasing trend in the adoption of AI for steering mechanism which simplifies driving effort, enhances engine performance, and increase fuel efficiency.

The Asia Pacific region is expected to witness the fastest CAGR of 22.7%, followed by the Middle East and Africa and South America. The high growth rate can be attributed to a strong AI hub in China, Japan, Singapore, and India, enabling automotive players to gain easy access to automotive-specific AI programs and services. The rising economy of Middle Eastern countries also offers promising growth opportunities to the MEA region. This can be accredited to the rising disposable income of people in the region, increasing interest of people to leverage semi-autonomous vehicles for commercial and personal uses, and favorable government regulations which help in regulating market growth.

Request a free sample copy or view report summary: Semi-Autonomous Vehicle Market Report

Semi-Autonomous Vehicle Market Report Highlights

• The level 3 automation segment is expected to emerge as the fastest-growing segment over the forecast period. Level 3 automation offers technological advancement with environmental detection capabilities, capable of making informed decisions such as overtake slow-moving vehicles, traffic maneuverability, and smart obstacle detection
• The commercial vehicle segment is expected to register the highest CAGR over the forecast period. The deployment of semi-autonomous driving solution in commercial vehicles ensures safe movement of products and goods, thus allowing the driver to maintain good health and posture
• The Asia Pacific region is expected to dominate the market over the forecast period. This can be attributed to the presence of the AI hubs in countries such as China, Japan, Singapore, and India; which offers a conducive environment for the semi-autonomous market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-semi-autonomous-vehicle-market

Semi-Autonomous Vehicle Market Segmentation

Grand View Research has segmented the global semi-autonomous vehicle market based on level of automation, vehicle type, and region:

Semi-Autonomous Vehicle Level of Automation Outlook (Volume, Million Units, 2017 - 2028)

• Level 1
• Level 2
• Level 3

Semi-Autonomous Vehicle Type Outlook (Volume, Million Units, 2017 - 2028)

• Passenger Car
• Commercial Vehicle

Semi-Autonomous Vehicle Regional Outlook (Volume, Million Units, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• South America
  • Brazil
• MEA

List of Key Players of the Semi-Autonomous Vehicle Market

• Audi AG
• BMW AG
• Continental AG
• Diamler AG (Mercedes Benz)
• Ford Motor Company
• General Motors
• Honda Motor Company
• Nissan Motor Company
• Toyota Motor Corporation
• Volvo Car Corporation
• Valeo S.A.
• Volkswagen AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.